Methods of producing hybrid Agaricus bisporus mushrooms strains derived or descended from at least one wild mushroom strain and having the specified traits of either greatly diminished sporulation or an absence of sporulation, and of obtaining postmeiotic offspring of nonsporlating basidiomycete fungi including Agaricus bisporus, are disclosed.

The claimed cauliflower mushroom plant named shirobanabijin has a higher primordium forming ability and a higher differentiating ability and, hence, higher productivity, higher production stability and higher crop yield. Further, the fruit body of shirobanabijin has a greater branch thickness and a moderately resilient flesh texture and, therefore, is less susceptible to breakage and shape collapse of petals and branches in the harvesting and the packaging thereof. Thus, shirobanabijin ensures efficient workability in the harvesting and the packaging. In addition, shirobanabijin is white and has higher product quality as compared with existing varieties.

The claimed cauliflower mushroom plant named shirobanabijin has a higher primordium forming ability and a higher differentiating ability and, hence, higher productivity, higher production stability and higher crop yield. Further, the fruit body of shirobanabijin has a greater branch thickness and a moderately resilient flesh texture and, therefore, is less susceptible to breakage and shape collapse of petals and branches in the harvesting and the packaging thereof. Thus, shirobanabijin ensures efficient workability in the harvesting and the packaging. In addition, shirobanabijin is white and has higher product quality as compared with existing varieties.

Disclosed is a Ganoderma Lucidum strain suitable for large-scale liquid fermentation, named as Ganoderma Lucidum G2, deposited with China General Microbiological Culture Collection Center under the accession number CGMCC No. 3982 on Jul. 20, 2010, and a method of mutation breeding the same and use of the strain. The Ganoderma Lucidum strain which belongs to Ganodermataceae, genus Ganoderma, species red Ganoderma Lucidum is obtained by artificial mutagenizing and breeding. The production of mycelia using the Ganoderma Lucidum strain G2 is 80120 times higher as compared with the production of mycelia using wild-type nave Ganoderma Lucidum strain. The mycelia produced using the Ganoderma Lucidum strain G2 have higher contents of main pharmaceutical ingredients. The Ganoderma Lucidum strain suitable for large-scale liquid fermentation can be used for manufacturing oral solution or beverage comprising Ganoderma mycelia or extracts of Ganoderma mycelia as main active ingredient.

Disclosed is a Ganoderma Lucidum strain suitable for large-scale liquid fermentation, named as Ganoderma Lucidum G2, deposited with China General Microbiological Culture Collection Center under the accession number CGMCC No. 3982 on Jul. 20, 2010, and a method of mutation breeding the same and use of the strain. The Ganoderma Lucidum strain which belongs to Ganodermataceae, genus Ganoderma, species red Ganoderma Lucidum is obtained by artificial mutagenizing and breeding. The production of mycelia using the Ganoderma Lucidum strain G2 is 80120 times higher as compared with the production of mycelia using wild-type nave Ganoderma Lucidum strain. The mycelia produced using the Ganoderma Lucidum strain G2 have higher contents of main pharmaceutical ingredients. The Ganoderma Lucidum strain suitable for large-scale liquid fermentation can be used for manufacturing oral solution or beverage comprising Ganoderma mycelia or extracts of Ganoderma mycelia as main active ingredient.

Disclosed is a Ganoderma Lucidum strain suitable for large-scale liquid fermentation, named as Ganoderma Lucidum G2, deposited with China General Microbiological Culture Collection Center under the accession number CGMCC No. 3982 on Jul. 20, 2010, and a method of mutation breeding the same and use of the strain. The Ganoderma Lucidum strain which belongs to Ganodermataceae, genus Ganoderma, species red Ganoderma Lucidum is obtained by artificial mutagenizing and breeding. The production of mycelia using the Ganoderma Lucidum strain G2 is 80120 times higher as compared with the production of mycelia using wild-type nave Ganoderma Lucidum strain. The mycelia produced using the Ganoderma Lucidum strain G2 have higher contents of main pharmaceutical ingredients. The Ganoderma Lucidum strain suitable for large-scale liquid fermentation can be used for manufacturing oral solution or beverage comprising Ganoderma mycelia or extracts of Ganoderma mycelia as main active ingredient.

Disclosed is a Ganoderma Lucidum strain suitable for large-scale liquid fermentation, named as Ganoderma Lucidum G2, deposited with China General Microbiological Culture Collection Center under the accession number CGMCC No. 3982 on Jul. 20, 2010, and a method of mutation breeding the same and use of the strain. The Ganoderma Lucidum strain which belongs to Ganodermataceae, genus Ganoderma, species red Ganoderma Lucidum is obtained by artificial mutagenizing and breeding. The production of mycelia using the Ganoderma Lucidum strain G2 is 80120 times higher as compared with the production of mycelia using wild-type nave Ganoderma Lucidum strain. The mycelia produced using the Ganoderma Lucidum strain G2 have higher contents of main pharmaceutical ingredients. The Ganoderma Lucidum strain suitable for large-scale liquid fermentation can be used for manufacturing oral solution or beverage comprising Ganoderma mycelia or extracts of Ganoderma mycelia as main active ingredient.

Exemplary embodiments of the present disclosure may include an isolated mycelium of Trametes versicolor designated as strain M2-101-03. Exemplary embodiments of the present disclosure may also include a method for propagating a Trametes versicolor mycelium, the method including culturing a mother culture, culturing a production culture, the production culture being a sub-culture of the mother culture, creating a liquid master inoculum using the production culture, diluting the liquid master inoculum to create a diluted liquid master inoculum, creating a biomass product using the diluted liquid master inoculum, slicing the biomass product for dehydration to create a sliced biomass product, dehydrating the sliced biomass product to create a dehydrated sliced biomass product, milling the dehydrated sliced biomass product to select a designated particle size of the dehydrated sliced biomass product, and screening the designated particle size of the dehydrated sliced biomass product.

Exemplary embodiments of the present disclosure may include an isolated mycelium of Trametes versicolor designated as strain M2-101-03. Exemplary embodiments of the present disclosure may also include a method for propagating a Trametes versicolor mycelium, the method including culturing a mother culture, culturing a production culture, the production culture being a sub-culture of the mother culture, creating a liquid master inoculum using the production culture, diluting the liquid master inoculum to create a diluted liquid master inoculum, creating a biomass product using the diluted liquid master inoculum, slicing the biomass product for dehydration to create a sliced biomass product, dehydrating the sliced biomass product to create a dehydrated sliced biomass product, milling the dehydrated sliced biomass product to select a designated particle size of the dehydrated sliced biomass product, and screening the designated particle size of the dehydrated sliced biomass product.

The present invention relates to fungi of Acremonium spp, wherein said fungi are purified or isolated from plants of the Brachiaria-Urochloa complex and wherein, when said fungi are inoculated into a plant, said plant has improved resistance to diseases and/or pests relative to an uninocualated control plant. The present invention also relates to plants inoculated with such fungi, products produced by the fungi and related genes, proteins and methods.